Clinical Trial Update: Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on stem cell transplantation as immunotherapy for hematologic malignancies. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Juvenile Myelomonocytic Leukemia
• Leukemia
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma
• Paroxysmal Nocturnal Hemoglobinuria

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED